KALEIGH COWART: Open Payments
NPI 1598273377 · MACON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,314 in 47 payments from 17 companies in 2025. Trend: 2023 $1,039 · 2024 $1,554 · 2025 $1,314
Food & beverage: $1,156Education: $158
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 5 | $287 |
| Regeneron Healthcare Solutions, Inc. | 6 | $178 |
| Verona Pharma, Inc. | 4 | $105 |
| SANOFI-AVENTIS U.S. LLC | 1 | $100 |
| AstraZeneca Pharmaceuticals LP | 5 | $93 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $81 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $73 |
| GlaxoSmithKline, LLC. | 4 | $72 |
| Grifols USA, LLC | 2 | $64 |
| Viatris Specialty LLC | 2 | $52 |
Products named: DUPIXENT, Ohtuvayre, GLASSIA, OFEV, Prolastin-C Liquid, NUCALA, YUPELRI, PURIFIED CORTROPHIN GEL.
Industry payments across GA — which companies pay providers there.
